Anti-Uroplakin II antibodies systems and methods
First Claim
Patent Images
1. An isolated antibody or isolated antigen binding fragment thereof comprising:
- heavy chain variable region complementarity determining region (CDR) sequences consisting of SEQ ID NOs;
5, 6, and 7; and
light chain variable region CDR sequences consisting of SEQ ID NOs;
8, 9, and 10 or SEQ ID NOs;
11, 12, and 13,wherein the antibody or antigen binding fragment thereof specifically binds to Uroplakin II comprising SEQ ID NO;
4.
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention is related to the anti-Uroplakin II antibodies, kits, cocktails, and use of anti-Uroplakin II antibodies for detection of cancer.
-
Citations
9 Claims
-
1. An isolated antibody or isolated antigen binding fragment thereof comprising:
- heavy chain variable region complementarity determining region (CDR) sequences consisting of SEQ ID NOs;
5, 6, and 7; andlight chain variable region CDR sequences consisting of SEQ ID NOs;
8, 9, and 10 or SEQ ID NOs;
11, 12, and 13,wherein the antibody or antigen binding fragment thereof specifically binds to Uroplakin II comprising SEQ ID NO;
4. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9)
- heavy chain variable region complementarity determining region (CDR) sequences consisting of SEQ ID NOs;
Specification